Leadership Team

Hemant has experience in both industry and consultancy, as part of wider global teams. He is primarily responsible for day-to-day functioning of Skyward Analytics including but not limited to project specific work, business development, finance, legal and operations.

Hemant comes with an enriched experience of developing pricing models, economic models, HTA submissions, and technical reviews of local and global economic models. He has co-authored multiple publications in both national and international journals.

Hemant’s therapeutic area expertise includes – Immunology and Dermatology, Oncology, Neuroscience, Cardiovascular, Ophthalmology, and Genetic disorders.

Amit is an experienced health economics modeller with 9 years of expertise in the HEOR and healthcare domain. He holds a master’s degree in Statistics. He has extensive experience in delivery of key HEOR deliverables including global health economic models and their technical reports, HTA submissions, technical reviews of local and global economic models.

Amit has co-authored multiple publications in peer-reviewed international journals. He has also contributed to manuscripts and scientific presentations, including abstracts, posters, oral presentations, and slide decks.

Amit’s therapeutic area expertise includes – Oncology, Ophthalmology, Mental health, Anti-microbial resistance, Respiratory, and Immunology.

Surabhi has 10 years of experience in the HEOR and healthcare domain. She holds a master’s degree in Pharmaceutics from Delhi University.

Surabhi has extensive experience of working on key HEOR deliverables including systematic & targeted literature reviews, treatment landscape studies, global value dossiers, manuscripts, HTA submission style reports, and scientific presentations (abstracts, posters, e-posters, oral presentations, slide-decks).

Surabhi’s therapeutic area of expertise includes – Oncology, Dermatology, Gastrointestinal diseases, Cardiovascular, Neurology, Psychiatry, Immunology, Metabolic disorders and Orphan/Rare diseases.

Shantanu Jawla has over 12 years of experience in the HEOR and healthcare domain, with expertise gained across both pharmaceutical industry and consulting settings. He holds a master’s in pharmacy (Pharmacology) from DIPSAR, University of Delhi, India.

His expertise includes systematic and targeted literature reviews, global value dossiers, HTA submissions, real-world evidence, and scientific writing.

He has worked across a broad range of therapeutic areas, including Cardiovascular, Neuroscience, Immunology, Respiratory, Oncology, Diabetes, and Rare Diseases, supporting evidence generation, market access, and value demonstration initiatives.